IDbyDNA
Salt Lake City
About IDbyDNA
We passionately believe that infectious disease patients should be treated with the same precision that cancer patients receive today. As our population increases, our economies become more global, and we continue over-usage of broad-spectrum antibiotics, infectious diseases are going to continue to spread and become more pernicious. Our clinical practices must evolve with disease to become more precise in our diagnostic and treatment tools. At IDbyDNA, our goal is to accelerate these solutions and uncover the microbial world to reduce infectious disease-associated morbidity and mortality
Company Facts
- Operating status: Closed
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $64.0M
- Funding stage: M&A
- Last round: Debt Financing (Dec 2020)
- Website: idbydna.com
Industries & Categories
Biotechnology, Health Care, Health Diagnostics, Life Science
Social Profiles
Canonical: https://fsome.com/organization/idbydna-153368 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.